227 related articles for article (PubMed ID: 9335082)
1. Kappa opioid mediated locomotor activity in the preweanling rat: role of pre- and postsynaptic dopamine receptors.
McDougall SA; Garmsen GM; Meier TL; Crawford CA
Psychopharmacology (Berl); 1997 Sep; 133(1):62-8. PubMed ID: 9335082
[TBL] [Abstract][Full Text] [Related]
2. Altered neurochemical and behavioral development of 10-day-old rats perinatally exposed to the kappa opioid agonist U-50,488H.
Shieh GJ; Walters DE
Neurosci Lett; 1994 Jul; 176(1):37-40. PubMed ID: 7970232
[TBL] [Abstract][Full Text] [Related]
3. Paradoxical effects of kappa-opioid stimulation on the locomotor activity and Fos immunoreactivity of the preweanling rat: role of dopamine receptors.
Duke MA; Meier TL; Bolanos CA; Crawford CA; McDougall SA
Behav Neurosci; 1997 Oct; 111(5):1114-22. PubMed ID: 9383529
[TBL] [Abstract][Full Text] [Related]
4. Effects of dorsal striatal infusions of R(-)-propylnorapomorphine on kappa-opioid-mediated locomotor activity in the young rat: possible role of the indirect pathway.
Charntikov S; Halladay LR; Herbert MS; Marquez EM; McDougall SA
Neuroscience; 2008 Aug; 155(3):603-12. PubMed ID: 18616989
[TBL] [Abstract][Full Text] [Related]
5. Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593.
Acri JB; Thompson AC; Shippenberg T
Synapse; 2001 Mar; 39(4):343-50. PubMed ID: 11169785
[TBL] [Abstract][Full Text] [Related]
6. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
Wachtel SR; Hu XT; Galloway MP; White FJ
Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
[TBL] [Abstract][Full Text] [Related]
7. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
8. Indirect dopamine agonists augment the locomotor activating effects of the kappa-opioid receptor agonist U-50,488 in preweanling rats.
McDougall SA; Rodarte-Freeman AL; Nazarian A
Dev Psychobiol; 1999 Apr; 34(3):183-93. PubMed ID: 10204094
[TBL] [Abstract][Full Text] [Related]
9. Role of dopamine D(1) receptors for kappa-opioid-mediated locomotor activity and antinociception during the preweanling period: a study using D(1) receptor knockout mice.
Karper PE; Nazarian A; Crawford CA; Drago J; McDougall SA
Physiol Behav; 2000 Feb; 68(4):585-90. PubMed ID: 10713301
[TBL] [Abstract][Full Text] [Related]
10. kappa-Opioid receptors in the substantia nigra pars reticulata mediate the U-50,488-induced locomotor activity of preweanling rats.
Collins RL; Zavala AR; Nazarian A; McDougall SA
Brain Res Dev Brain Res; 2000 Jan; 119(1):97-103. PubMed ID: 10648876
[TBL] [Abstract][Full Text] [Related]
11. Effects of kappa receptor agonists on D1 and D2 dopamine agonist and antagonist-induced behaviors.
Marin C; Engber TM; Chaudhuri P; Peppe A; Chase TN
Psychopharmacology (Berl); 1996 Jan; 123(2):215-21. PubMed ID: 8741947
[TBL] [Abstract][Full Text] [Related]
12. Effects of acute dopamine depletion on responsiveness to D1 and D2 receptor agonists in infant and weanling rat pups.
Moody CA; Spear LP
Psychopharmacology (Berl); 1992; 107(1):39-49. PubMed ID: 1350350
[TBL] [Abstract][Full Text] [Related]
13. Differential modulation of the D1-like- and D2-like dopamine receptor-induced locomotor responses by group II metabotropic glutamate receptors in the rat nucleus accumbens.
David HN; Abraini JH
Neuropharmacology; 2001 Sep; 41(4):454-63. PubMed ID: 11543765
[TBL] [Abstract][Full Text] [Related]
14. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
Pollack AE; Yates TM
Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
[TBL] [Abstract][Full Text] [Related]
15. Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats.
Dreher JK; Jackson DM
Brain Res; 1989 May; 487(2):267-77. PubMed ID: 2525062
[TBL] [Abstract][Full Text] [Related]
16. Kappa opioid-mediated behavioral sensitization in the preweanling rat: relationship to Fos immunoreactivity.
Collins RL; Zavala AR; Ingersoll VY; Duke MA; Crawford CA; McDougall SA
Psychopharmacology (Berl); 1998 Jun; 137(3):282-91. PubMed ID: 9683006
[TBL] [Abstract][Full Text] [Related]
17. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens.
Rouillon C; Abraini JH; David HN
Hippocampus; 2007; 17(11):1028-36. PubMed ID: 17604350
[TBL] [Abstract][Full Text] [Related]
18. Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site.
Gong W; Neill DB; Lynn M; Justice JB
Neuroscience; 1999; 93(4):1349-58. PubMed ID: 10501459
[TBL] [Abstract][Full Text] [Related]
19. Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats.
Perreault ML; Graham D; Scattolon S; Wang Y; Szechtman H; Foster JA
Psychopharmacology (Berl); 2007 Nov; 194(4):485-96. PubMed ID: 17619861
[TBL] [Abstract][Full Text] [Related]
20. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors?
White FJ; Bednarz LM; Wachtel SR; Hjorth S; Brooderson RJ
Pharmacol Biochem Behav; 1988 May; 30(1):189-93. PubMed ID: 2902644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
